Matthew E. Hardee
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Hematology top 5%
- Erythropoietin and Anemia Treatment
Papers in
- Oncology 9
- PARP inhibition in cancer therapy 3
-
- Radiation Therapy and Dosimetry 3
- Prostate Cancer Diagnosis and Treatment 3
- Prostate Cancer Treatment and Research 3
- Co-authors
- David Zagzag (2 shared papers)Mark W. Dewhirst (11 shared papers)Kimberly Blackwell (5 shared papers)Murat O. Arcasoy (4 shared papers)John P. Kirkpatrick (5 shared papers)Ariel E. Marciscano (3 shared papers)Mary Helen Barcellos‐Hoff (2 shared papers)Zahid N. Rabbani (6 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)Medical Physics (2 papers)PLoS ONE (2 papers)British Journal of Cancer (2 papers)Technology in Cancer Research & Treatment (2 papers)
- Partner nations
- United StatesNetherlandsSouth Korea
In The Last Decade
Matthew E. Hardee
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Genetics 302
- Hematology 282
- Cancer Research 317
- Oncology 397
- Radiation 70
Countries citing papers authored by Matthew E. Hardee
This map shows the geographic impact of Matthew E. Hardee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Hardee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Hardee more than expected).
Fields of papers citing papers by Matthew E. Hardee
This network shows the impact of papers produced by Matthew E. Hardee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Hardee. The network helps show where Matthew E. Hardee may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Hardee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 373 | |
| 2 | 2012 | 202 | |
| 3 | 2006 | 174 | |
| 4 | 2013 | 94 | |
| 5 | 2007 | 86 | |
| 6 | 2014 | 75 | |
| 7 | 2015 | 56 | |
| 8 | 2005 | 54 | |
| 9 | 2006 | 51 | |
| 10 | 2009 | 48 | |
| 11 | 2008 | 43 | |
| 12 | 2012 | 41 | |
| 13 | 2011 | 38 | |
| 14 | 2013 | 30 | |
| 15 | 2016 | 26 | |
| 16 | Squamous cell carcinoma of the prostate. | 2011 | 22 |
| 17 | 2008 | 18 | |
| 18 | 2015 | 15 | |
| 19 | 2011 | 13 | |
| 20 | 2006 | 10 |
About Matthew E. Hardee
Matthew E. Hardee is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiation, Hematology and Molecular Biology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (6 papers), Erythropoietin and Anemia Treatment (6 papers), Glioma Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Radiation Therapy and Dosimetry (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers), PARP inhibition in cancer therapy (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Genetics (302 citations), Hematology (282 citations), Cancer Research (317 citations), Oncology (397 citations) and Radiation (70 citations). Matthew E. Hardee has collaborated with scholars based in United States, Netherlands and South Korea. Frequent co-authors include David Zagzag, Mark W. Dewhirst, Kimberly Blackwell, Murat O. Arcasoy, John P. Kirkpatrick, Ariel E. Marciscano, Mary Helen Barcellos‐Hoff, Zahid N. Rabbani, Scott Lonning and Ashwatha Narayana. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Medical Physics, PLoS ONE, British Journal of Cancer and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.